GlassScriptPhysician profile
Jessa Hoffman
NPI 1558868430
$1,947.56
in general payments reported to CMS, 2019-2025
8 companies · $978 in 2025
The $978 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.79 · 2023: $495 · 2024: $424 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,144 · Travel and Lodging: $593 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.96 |
| Travel and Lodging | $593.02 |
| Education | $160.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,333.01 | 2022-2025 | Surpass Evolve, Neuroform Ez 3, Target |
| Microvention, INC. | $185.57 | 2023-2025 | Stent |
| Globus Medical, INC. | $148.92 | 2025 | Excelsius Gps |
| Medical Device Business Services, INC. | $133.40 | 2024 | Trufill, Teligen |
| Boston Scientific Corporation | $78.85 | 2024 | |
| Medtronic, INC. | $32.36 | 2025 | Adaptix Interbody System With Titan Nanolock Surface Technology, Solitaire X, Pipeline |
| Abbott Laboratories | $21.99 | 2024 | Perclose Prostyle |
| Abbvie INC. | $13.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessa Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.